Skip to Main Content

Editor’s note: A recording of this conversation is embedded below. 

Each week, STAT Plus subscribers enjoy exclusive interviews with STAT reporters and leaders in health care. This week, STAT’s co-founder and executive editor, Rick Berke, will be joined by Pharmalot’s Ed Silverman to chat about the state of the pharmaceutical industry. They’ll discuss how pharma might cope with the impact of Covid-19, from supply chain challenges and regulatory interactions, to ensuring equitable access to potential treatments for the virus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!